Corestreet Logo

Eagle Pharmaceuticals Inc (EGRX) Insider Trading

Total insider buys:
  • $6,655,741.73
Total insider sells:
  • $139,852,839.96
Most recent insider trade:
  • Nov. 1, 2023
Most active insider trader:
  • Proquest Investments Iv, L.P.
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 1, 2023CEO10,925$13.82Sell$150,983.50
Oct. 2, 2023CEO9,511$15.23Sell$144,852.53
May 15, 2023CEO15,000$21.07Sell$316,050.00
May 11, 2023CEO15,000$20.71Sell$310,650.00
Sept. 6, 2022Director6,800$30.99Sell$210,732.00
Oct. 25, 2019Director15,437$63.57Sell$981,330.09
Oct. 23, 2019Director200$62.58Sell$12,516.00
Oct. 21, 2019Director3,849$62.56Sell$240,793.44
Oct. 17, 2019Director13,842$62.58Sell$866,232.36
Oct. 15, 2019Director3,909$62.63Sell$244,820.67
Oct. 10, 2019Director7,829$60.16Sell$470,992.64
Oct. 7, 2019Director4,901$60.11Sell$294,599.11
Sept. 17, 2019Director100$60.00Sell$6,000.00
Sept. 11, 2019Director1,112$60.06Sell$66,786.72
May 10, 2019Director159,223$56.81Sell$9,045,458.63
April 1, 2019CEO24,975$50.15Sell$1,252,496.25
March 1, 2019CEO24,428$51.17Sell$1,249,980.76
Feb. 1, 2019CEO30,085$41.54Sell$1,249,730.90
Jan. 3, 2019CEO31,569$39.49Sell$1,246,659.81
March 6, 2018Director2,340$53.94Sell$126,219.60
Aug. 16, 2017CFO350$55.45Buy$19,407.50
Aug. 9, 2017Director20,400$49.07Buy$1,001,028.00
June 12, 2017CFO350$71.49Buy$25,021.50
May 19, 2017Insider255$79.69Buy$20,320.95
May 16, 2017Insider200$82.24Buy$16,448.00
April 25, 2017Major Shareholder54,180$88.38Sell$4,788,428.40
April 3, 2017Major Shareholder91,332$83.09Sell$7,588,775.88
March 29, 2017Major Shareholder106,468$83.01Sell$8,837,908.68
March 28, 2017Major Shareholder6,182$83.02Sell$513,229.64
March 27, 2017Major Shareholder39,431$83.00Sell$3,272,773.00
March 23, 2017EVP14,125$81.07Sell$1,145,113.75
March 23, 2017Major Shareholder1,200$83.05Sell$99,660.00
March 22, 2017Director6,000$79.44Buy$476,640.00
March 21, 2017Insider61$83.98Buy$5,122.78
March 20, 2017Major Shareholder100,000$82.06Sell$8,206,000.00
March 9, 2017Insider450$77.84Buy$35,028.00
Jan. 4, 2017Major Shareholder65,114$85.16Sell$5,545,108.24
Dec. 13, 2016Director10,000$75.01Sell$750,100.00
Nov. 28, 2016Director5,000$78.66Sell$393,300.00
Nov. 11, 2016Major Shareholder34,486$85.15Sell$2,936,482.90
Nov. 9, 2016Major Shareholder153,830$79.29Sell$12,197,180.70
Nov. 7, 2016Major Shareholder5,030$75.39Sell$379,211.70
Nov. 4, 2016Major Shareholder245,770$71.02Sell$17,454,585.40
Sept. 30, 2016Major Shareholder22,100$70.06Sell$1,548,326.00
Sept. 29, 2016Major Shareholder77,900$70.04Sell$5,456,116.00
Sept. 21, 2016Major Shareholder99,795$66.17Sell$6,603,435.15
Sept. 8, 2016Major Shareholder70,925$62.50Sell$4,432,812.50
Aug. 24, 2016Major Shareholder28,870$63.00Sell$1,818,810.00
Aug. 17, 2016Major Shareholder99,795$61.36Sell$6,123,421.20
Aug. 16, 2016Major Shareholder60,150$61.67Sell$3,709,450.50
First«1 of 2»Last

  • Insiders are both buying and selling Eagle Pharmaceuticals Inc stock.

  • The insider traders at Eagle Pharmaceuticals Inc are: Proquest Investments Iv, L.P., Scott Tarriff, Hudson Executive Capital Lp, David Pernock, Steven L Krill, Douglas L Braunstein, Pete A Meyers, Richard A Edlin, Sander A Flaum, Jay Moorin, Sander A. Flaum, Michael Graves, Proquest Management Llc, and Steven B Ratoff

  • The most active insider trader at Eagle Pharmaceuticals Inc is Proquest Investments Iv, L.P. with 20 trades.

  • Proquest Investments Iv, L.P. has sold the most Eagle Pharmaceuticals Inc stock with a total value of $107,816,295.02.

  • Jay Moorin has bought the most Eagle Pharmaceuticals Inc stock with a total value of $9,999,990.00.

  • The most recent insider trade for Eagle Pharmaceuticals Inc was on Nov. 1, 2023.

  • The single biggest insider buy for Eagle Pharmaceuticals Inc was from Jay Moorin with a total value of $4,999,995.00 on Feb. 18, 2014.

  • The single biggest insider sell for Eagle Pharmaceuticals Inc was from Proquest Investments Iv, L.P. with a total value of $17,454,585.40 on Nov. 4, 2016.